SCHEMBL30797892

SCHEMBL30797892

CC(C)(C)OC(=O)NCCCCOCCNc1nc(-c2cnns2)cc2c1cnn2C1CCCCO1

nearest known ligand 0.42

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 3/20 0.42
▸ BRD4 O60885 17/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30797724 0.89 ATR (0.43) ATRBRD4
SCHEMBL30797579 0.88 ATR (0.41) ATRBRD4
SCHEMBL30797685 0.87 ATR (0.46) ATRBRD4
SCHEMBL30798114 0.85 ATR (0.42) ATRBRD4
SCHEMBL30797700 0.82 ATR (0.47) ATRBRD4
SCHEMBL30797730 0.78 ATR (0.44) ATRBRD4
SCHEMBL30869078 0.78 ATR (0.45) ATRBRD4
SCHEMBL30797851 0.77 ATR (0.43) ATRBRD4
SCHEMBL30869074 0.77 ATR (0.43) ATRBRD4
SCHEMBL30797897 0.77 ATR (0.46) ATRBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4584266-A1 NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF Cambridge Enterprise Limited (GB) 2025-07-16 — — EP disclosed
WO-2024052701-A1 NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF CAMBRIDGE ENTERPRISE LIMITED (GB) 2024-03-14 — — WO disclosed
Send feedback